The findings indicated a negative association between RIPK2 expression and tumor stemness in PCPG, LGG, LUSC, LIHC, KIRC and HNSC, while a positive correlation was observed in other contexts (supplementary Figure 1C). The gene discussed is RIPK2; the disease is neoplasm.